Mesoblast Limited
Level 39
55 Collins Street
Melbourne 3000
AUSTRALIA

+61 3 9639 6036

Email:info@mesoblast.com

For media and shareholder inquiries:

Julie Meldrum
Corporate Communications Director
E: julie.meldrum@mesoblast.com
+ 61 (0) 419 228 128

 

Last Share Price

June 26 - Mesoblast Featured on ABC-TV's Catalyst Program

June 24 - First Patients In Bone Marrow Transplant Trial Show Earlier Engraftment. Potential For Accelerated Phase 3 Program

May 14 - Heart Muscle Function Improved After Single Lowest-Dose Injection of "Off-The-Shelf" Stem Cells In Patients With Heart Failure

30 March 2009 - RBS Equities Research

17 March 2009 - Lodge Partners Research Report

27 February 2009 - ABN AMRO Equity Research

May 2009 - Chairman’s Letter

May 2008 - Issue Nine